[Solved] Microdosing truffles and serotonin syndrome

Serotonin syndrome is a rare but potentially life-threatening condition in which a dangerously high concentration of serotonin develops in the body. This can occur when combining serotonergic agents, such as antidepressants (e.g., SSRIs, SNRIs, MAO inhibitors), with certain psychedelics, particularly MDMA. Symptoms range from confusion, muscle stiffness, and increased heart rate to high fever and, in severe cases, coma or death.

For classic psychedelics such as psilocybin or LSD the risk of serotonin syndrome is minimal even at high doses — especially if no MAO inhibitors are used. Recent insights studies even show that psilocybin can be safely used in combination with SSRIs such as paroxetine, sertraline, or fluoxetine, albeit with a somewhat blunted effect. With MAOIs, the situation is different: these can inhibit the breakdown of psilocybin and potentiate its effects, which increases the risk of serotonin syndrome.

Microdosing with truffles (psilocybin) increases in most cases not the risk of serotonin syndrome. After all, you are using even less psilocybin than with macrodosing. With microdosing, the dosage is so low that the effect on serotonin levels is usually negligible. However, if you take medication that affects the serotonin system, such as MAOIs or painkillers (tramadol), then an increased risk may indeed arise, although less than with high doses.

Briefly: Without serotonergic medication, microdosing with truffles is safe and does not cause serotonin syndrome. With serotonergic medication, the risk can increase, but the chance is small.